$VNDA 3 SEC Filings

Filed On	Filing
08 Jun 2026	Form 3: McGuire Daniel Patrick, SVP, GC and Secretary Holds 1,732 shares of Common Stock
24 Apr 2026	Form 3: Duncan Charles Cliff, Director No securities owned
13 Apr 2026	Form 3: Polymeropoulos Christos Vasilios Mihael, Senior VP, Medical Director Holds 129,791 shares of Common Stock
13 Apr 2026	Form 3: Howell Scott Laverne, VP and Chief People Officer Holds 99,360 shares of Common Stock
17 Mar 2023	Form 3: Honore Tage, Director No securities owned
24 Mar 2020	Form 3: Moran Kevin Patrick, VP, Acting CFO & Treasurer Holds 14,237 shares of Common Stock
19 Feb 2020	Form 3: Mitchell Stephen Ray, Director Holds 200 shares of Common Stock
28 Oct 2019	Form 3: Ward Anne Sempowski, Director No securities owned
21 Aug 2019	Form 3: Wijkstrom Joakim, SVP, Chief Marketing Officer No securities owned
21 Aug 2019	Form 3: Jones Aranthan Ii, Chief Corp. Affairs Officer Holds 60,000 shares of Common Stock
24 Apr 2019	Form 3: Chrousos Phaedra, Director No securities owned
14 Aug 2018	Form 3: Williams Timothy, SVP & General Counsel No securities owned
31 Mar 2017	Form 3: Birznieks Gunther, SVP, Business Development Holds 126,934 shares of Common Stock
21 Dec 2015	Form 3: Bate Kenneth, Director No securities owned
15 Sep 2015	Form 3: Gulino Richard L., SVP & General Counsel No securities owned
09 Sep 2015	Form 3: Reverberi Gian Piero, SVP, General Manager Europe No securities owned
18 May 2015	Form 3: Flynn James E, 10% owner and 5 others Holds 751,978 shares of Common Stock
21 Apr 2015	Form 3: Gibbs Thomas Edward, SVP, Chief Commercial Officer No securities owned
24 Dec 2014	Form 3: Flynn James E, 10% owner and 6 others Holds 610,588 shares of Common Stock
17 Apr 2013	Form 3: Baroldi Paolo, SVP & Chief Medical Officer Holds 14,125 shares of Common Stock

Comments